TREAT Act

Hozzl · 2022-12-30T07:04:00Z

Explore the details of Senate Bill 2866 TREAT Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/30/2022, 7:04 AM

Congressional Summary of S 2866

Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act

This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2866

Bill S 2866 is currently in the status of Bill Introduced since September 28, 2021. Bill S 2866 was introduced during Congress 117 and was introduced to the Senate on September 28, 2021. Bill S 2866's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 28, 2021

Bipartisan Support of Bill S 2866

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2866

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Drug therapy

- Emergency medical services and trauma care

- Health care coverage and access

- Health facilities and institutions

- Health technology, devices, supplies

- Immunology and vaccination

- Infectious and parasitic diseases

- State and local government operations

Alternate Title(s) of Bill S 2866

TREAT Act

A bill to prohibit the Secretary of Health and Human Services from restricting direct access by health care facilities to COVID-19 monoclonal antibody therapies.

TREAT Act

Treatment Restoration for Emergency Antibody Therapeutics Act